Strategic Partnership with Medtronic

October 10 2016

Effective as of August 31st 2016, Spectrum Medical Ltd and Medtronic Inc. have entered into a strategic and exclusive relationship for the distribution of Spectrum Medical’s new Quantum Perfusion Systems. The initial three year term includes all markets in Europe, Africa, The Middle East, Central Asia, Canada, Australia and New Zealand. 

Following five years of intensive Research and Development Spectrum Medical will launch in 2017 an exciting new generation of Extracorporeal Technologies and Integrated Patient Safety Systems designed specifically for cardiopulmonary bypass and ECMO therapies.

Steve Turner, Spectrum Medical’s CEO stated that: “Spectrum Medical and Medtronic have enjoyed a proven track record of working successfully together in the various European markets and have become synergistic in their vision for the future of global Perfusion Technologies. Spectrum Medical’s partnership with Medtronic will enable customers worldwide to have greater access to these exciting new technologies.”